NEW YORK (GenomeWeb News) – Pharmacogenomics test developer and specialty lab company Delphic has acquired the diagnostics business of iQur.

London-based iQur specializes in liver diagnostics and therapies. Delphic, which also is based in London, said in a statement that the acquisition would enable it to "leverage its capabilities and infrastructure to offer improved services in infectious diseases to the clinical and clinical trials markets, and to access the growing market for blood-borne virus screening."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Vivek Murthy is no longer the surgeon general of the US, the Associated Press reports.

People around the globe took to the streets to support science — some with signs.

Parents who learn of their increased genetic risk of disease also contend with telling their children about theirs, the New York Times writes.

In PLOS this week: loci linked to body mass index measurements, long non-coding RNA expression and urothelial carcinoma prognosis, and more.